ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,503Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 1006

$623K Total Retail Price of All Prescriptions

Rank: 142 out of 1006

310 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 310 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,316 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 550 547 1 8
FUROSEMIDE 385 334 2 6
LEVOTHYROXINE SODIUM 363 351 3 2
METOPROLOL TARTRATE 308 297 4 7
SIMVASTATIN 285 256 5 1
LISINOPRIL 259 241 6 3
AMLODIPINE BESYLATE 246 217 7 4
MIRTAZAPINE 237 225 8 26
TRAZODONE HCL 223 210 9 21
DONEPEZIL HCL 179 167 10 17
RISPERIDONE 177 153 11 40
OMEPRAZOLE 172 159 12 9
GABAPENTIN 166 160 13 20
POTASSIUM CHLORIDE 146 131 14 30
NAMENDA 136 127 15 34
SERTRALINE HCL 120 102 16 19
EXELON 119 103 17 99
METFORMIN HCL 117 111 18 10
ESCITALOPRAM OXALATE 113 110 19 27
CITALOPRAM HBR 105 96 20 24
METOPROLOL SUCCINATE 102 91 21 12
PANTOPRAZOLE SODIUM 99 85 22 32
LANTUS 97 88 23 43
ATORVASTATIN CALCIUM 96 75 24 5
CARVEDILOL 95 82 25 36
TAMSULOSIN HCL 89 65 26 23
CYMBALTA 82 82 27 41
GLIPIZIDE 76 73 28 69
ISOSORBIDE MONONITRATE ER 75 75 29 59
QUETIAPINE FUMARATE 74 68 30 45
HYDROCHLOROTHIAZIDE 74 40 30 11
SPIRONOLACTONE 73 60 32 71
PRAVASTATIN SODIUM 72 49 33 15
LEVETIRACETAM 70 60 34 72
NOVOLIN R 70 70 34 158
DIVALPROEX SODIUM 70 70 34 53
HALOPERIDOL 67 42 37 129
NEXIUM 66 58 38 28
CLOPIDOGREL 60 60 39 46
ALENDRONATE SODIUM 59 59 40 29
PREDNISONE 59 57 40 33
LACTULOSE 56 43 42 104
JANUVIA 56 51 42 49
RANITIDINE HCL 54 43 44 63
LOSARTAN POTASSIUM 54 45 44 22
CARBIDOPA-LEVODOPA 52 52 46 80
IPRATROPIUM-ALBUTEROL 50 49 47 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.